Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
no amino-acid sequence Reference salt: Iodide salt CAS for iodide salt: 42464-96-0 PubChem CID for iodide record: 66522933 PubChem CID for cation: 950107 Iodide-salt formula: C10H11IN2 Iodide-salt molecular weight: 286.11 g/mol Cation formula: C10H11N2+ Cation molecular weight: 159.21 g/mol Primary research target: Nicotinamide N-methyltransferase (NNMT) Reference potency: approximately 1.2 M IC50 under a specified in-vitro assay Purity specification: 99% by HPLC, subject to lot-specific report Identity specification: Mass-spectrometry confirmation, subject to lot-specific report Product format: Lyophilized or dried research powder as stated on the lot label Release: QC-released under SaiyanMed specifications General sealed storage: 20C, protected from light and moisture Expiration: Use the date and stability statement on the lot-specific label or COA Salt Form & Molecular-Weight Basis Name Formula Molecular weight Identifier Use in calculations Do not mix salt mass and cation-equivalent mass A vial labeled by iodide-salt mass is not numerically equivalent to the same mass of free cation
Questions to Ask at Your Screening When you disclose GLP-1 use during your screening, these questions help clarify the protocol specific to your situation and the programs requirements
Weight loss medications require evaluation by a licensed clinician
A serious cardiovascular episode (atrial fibrillation) was reported in a male individual randomized to placebo but on liraglutide 3.0 mg at the time of the event, which occurred after 707 days
Wang W, Lin W, Hong B, Li X, Zhang M, Zhang L, et al
11 Conclusion Glucagon-like peptide-1 receptor agonists are pivotal in managing T2DM and obesity, enhancing glycaemic control by boosting insulin secretion, reducing glucagon levels, delaying gastric emptying, and promoting satiety
